Stuart Poulton

EVP, Chief Development Officer, Karyopharm Therapeutics Inc.

Bought, 12 months

$0.0M

Sold, 12 months

$0.1M

Companies

Latest trade

Jul 28, 2026

Companies

Karyopharm Therapeutics Inc.EVP, Chief Development Officer −$0.1M

Trades

KPTI Sold 189 shares at $7.10 $0.0M Jul 28

KPTI Sold 403 shares at $9.50 $0.0M May 14

KPTI Sold 5,101 shares at $9.41 $0.0M Mar 2

KPTI Sold 378 shares at $8.63 $0.0M Feb 17

Open-market trades from SEC Form 4 only: no grants, option exercises or gifts. People are matched by the name on their filings, so two people with the same name share this page. For information only — not investment advice.